|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 100.7 INR | +1.61% |
|
-2.45% | -1.39% |
Bal Pharma Limited reported earnings results for the fourth quarter ended March 31, 2023. For the fourth quarter, the company reported sales was INR 824.51 million compared to INR 740.49 million a year ago. Revenue was INR 826.39 million compared to INR 777.53 million a year ago.
Net income was INR 16.01 million compared to INR 19.71 million a year ago. Basic earnings per share from continuing operations was INR 1.03 compared to INR 1.33 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -1.39% | 18.64M | |
| +31.37% | 595B | |
| -2.60% | 367B | |
| +20.83% | 334B | |
| +5.69% | 289B | |
| +14.83% | 239B | |
| +9.93% | 211B | |
| -6.95% | 203B | |
| +10.77% | 171B | |
| +0.10% | 163B |
BAL PHARMA LIMITED 